Published in Surgery on January 30, 2008
A practical look at the chemistry and biology of hydrogen sulfide. Antioxid Redox Signal (2012) 1.60
H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal (2009) 1.30
Inhibition of Hydrogen Sulfide-induced Angiogenesis and Inflammation in Vascular Endothelial Cells: Potential Mechanisms of Gastric Cancer Prevention by Korean Red Ginseng. J Ginseng Res (2012) 0.97
Hydrogen sulfide is a partially redox-independent activator of the human jejunum Na+ channel, Nav1.5. Am J Physiol Gastrointest Liver Physiol (2011) 0.94
Mechanisms of action of the gasotransmitter hydrogen sulfide in modulating contractile activity of longitudinal muscle of rat ileum. J Gastrointest Surg (2010) 0.91
Emergent role of gasotransmitters in ischemia-reperfusion injury. Med Gas Res (2011) 0.89
Long-term release of a thiobenzamide from a backbone functionalized poly(lactic acid). Polym Chem (2015) 0.89
Hydrogen sulfide modulates contractile function in rat jejunum. J Surg Res (2011) 0.88
Bacteria-derived hydrogen sulfide promotes IL-8 production from epithelial cells. Biochem Biophys Res Commun (2009) 0.88
Role of hydrogen sulfide as a gasotransmitter in modulating contractile activity of circular muscle of rat jejunum. J Gastrointest Surg (2011) 0.87
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. Br J Pharmacol (2015) 0.80
In vitro-controlled release delivery system for hydrogen sulfide donor. AAPS PharmSciTech (2014) 0.79
Hemin and Zinc Protoporphyrin IX Affect Granisetron Constipating Effects In Vitro and In Vivo. ISRN Gastroenterol (2013) 0.77
Hydrogen Sulfide, Oxidative Stress and Periodontal Diseases: A Concise Review. Antioxidants (Basel) (2016) 0.75
Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J (2002) 6.89
Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev (2005) 2.73
The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology (2006) 2.08
Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon. Gastroenterology (2006) 1.66
Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol (2003) 1.59
Hydrogen sulphide--a novel mediator of inflammation? Curr Opin Pharmacol (2006) 1.38
Pharmacology of transmission to gastrointestinal muscle. Curr Opin Pharmacol (2002) 1.13
Haem oxygenase in enteric nervous system of human stomach and jejunum and co-localization with nitric oxide synthase. Neurogastroenterol Motil (2001) 1.02
Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl (2003) 1.01
The role and interactions of nitric oxide (NO), carbon monoxide (CO), and prostanoids in the pathogenesis of postoperative ileus in rats. J Gastrointest Surg (2004) 0.88
Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut (2012) 10.56
Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery (2007) 6.62
Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery (2007) 4.72
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology (2004) 4.04
Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol (2009) 2.96
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology (2002) 2.76
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg (2008) 2.66
CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology (2010) 2.23
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery (2005) 2.10
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg (2008) 2.04
Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis (2005) 2.02
Small bowel obstruction-who needs an operation? A multivariate prediction model. World J Surg (2010) 1.94
Peroral endoscopic drainage/debridement of walled-off pancreatic necrosis. Ann Surg (2007) 1.76
Simulation-based mastery learning improves patient outcomes in laparoscopic inguinal hernia repair: a randomized controlled trial. Ann Surg (2011) 1.71
Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery (2011) 1.64
Suicide in patients with pancreatic cancer. Cancer (2010) 1.62
Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract (2004) 1.58
Sodium current in human intestinal interstitial cells of Cajal. Am J Physiol Gastrointest Liver Physiol (2003) 1.58
Pancreaticobiliary and duodenal perforations after periampullary endoscopic procedures: diagnosis and management. Arch Surg (2007) 1.56
Social media in surgical education and practice. Surgery (2011) 1.50
A comparison of direct endoscopic necrosectomy with transmural endoscopic drainage for the treatment of walled-off pancreatic necrosis. Gastrointest Endosc (2009) 1.47
Peripancreatic collections in acute pancreatitis: correlation between computerized tomography and operative findings. World J Gastroenterol (2010) 1.46
Long-term outcome of 254 complex incisional hernia repairs using the modified Rives-Stoppa technique. World J Surg (2007) 1.42
Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg (2005) 1.42
Scientific data from clinical trials: investigators' responsibilities and rights. Surg Endosc (2002) 1.39
Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol (2004) 1.36
Iatrogenic hepatic artery pseudoaneurysms: an uncommon complication after hepatic, biliary, and pancreatic procedures. Ann Vasc Surg (2003) 1.36
Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant (2010) 1.34
Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg (2007) 1.34
Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics. Can J Anaesth (2005) 1.33
Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis. Am J Physiol Gastrointest Liver Physiol (2004) 1.29
Mucinous cystadenocarcinoma of the appendix. The controversy persists: a review. Hepatogastroenterology (2003) 1.24
Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol (2008) 1.24
Forgotten pioneers of pancreatic surgery: beyond the favorite few. Ann Surg (2008) 1.24
Esophagogastroduodenoscopy-associated gastrointestinal perforations: a single-center experience. Surgery (2010) 1.24
Regional uptake of meal fatty acids in humans. Am J Physiol Endocrinol Metab (2003) 1.23
The natural history of the incidentally discovered small simple pancreatic cyst: long-term follow-up and clinical implications. AJR Am J Roentgenol (2005) 1.22
Cytoskeletal modulation of sodium current in human jejunal circular smooth muscle cells. Am J Physiol Cell Physiol (2003) 1.22
Effects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits. Auton Neurosci (2006) 1.21
Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include "moderately severe acute pancreatitis". Am J Gastroenterol (2009) 1.20
Altered expression of Ano1 variants in human diabetic gastroparesis. J Biol Chem (2011) 1.19
Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis (2009) 1.16
Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am J Physiol Regul Integr Comp Physiol (2004) 1.16
ICAM-1 expression determines malignant potential of cancer. Surgery (2007) 1.15
Diagnosis and contemporary management of anastomotic leaks after gastric bypass for obesity. J Am Coll Surg (2006) 1.15
Cystic neoplasms of the pancreas; what a clinician should know. Cancer Treat Rev (2005) 1.13
Clinical management after bariatric surgery: value of a multidisciplinary approach. Mayo Clin Proc (2006) 1.12
Visceral and subcutaneous adipose tissue diacylglycerol acyltransferase activity in humans. Obesity (Silver Spring) (2009) 1.12
Sodium current in human jejunal circular smooth muscle cells. Gastroenterology (2002) 1.12
Carbon monoxide reverses diabetic gastroparesis in NOD mice. Am J Physiol Gastrointest Liver Physiol (2010) 1.11
Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? HPB (Oxford) (2009) 1.10
Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality. Pancreatology (2010) 1.08
Open and laparoscopic Roux-en-Y gastric bypass: our techniques. J Gastrointest Surg (2007) 1.08
Synaptic plasticity in myenteric neurons of the guinea-pig distal colon: presynaptic mechanisms of inflammation-induced synaptic facilitation. J Physiol (2007) 1.08
Psychosocial factors and 2-year outcome following bariatric surgery for weight loss. Obes Surg (2003) 1.07
Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management. Ann Surg (2010) 1.06
Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas (2003) 1.06
Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg (2010) 1.06
Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc (2008) 1.06
Coordinated, diurnal hexose transporter expression in rat small bowel: implications for small bowel resection. Surgery (2007) 1.05
Primary pancreatic cystic neoplasms revisited. Part I: serous cystic neoplasms. Surg Oncol (2011) 1.05
The diurnal periodicity of hexose transporter mRNA and protein levels in the rat jejunum: role of vagal innervation. Surgery (2006) 1.05
CT findings of walled-off pancreatic necrosis (WOPN): differentiation from pseudocyst and prediction of outcome after endoscopic therapy. Eur Radiol (2008) 1.04
The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients. Surgery (2006) 1.02
Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery. Obesity (Silver Spring) (2007) 1.02
Mechanisms of glucose uptake in intestinal cell lines: role of GLUT2. Surgery (2011) 1.02
Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg (2012) 1.02
Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma. J Gastrointest Surg (2009) 1.00
Anesthesiologists, general surgeons, and tobacco interventions in the perioperative period. Anesth Analg (2004) 1.00
Endoscopic ultrasound (EUS)-guided angiotherapy of refractory gastrointestinal bleeding. Am J Gastroenterol (2007) 0.99
Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. Surgery (2012) 0.99
Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrinol Metab (2013) 0.98
Celiac artery stenosis: an underappreciated and unpleasant surprise in patients undergoing pancreaticoduodenectomy. J Am Coll Surg (2007) 0.98
Complications of temporary pancreatic stent insertion for pancreaticojejunal anastomosis during pancreaticoduodenectomy. Gastrointest Endosc (2004) 0.97
Sacral neuromodulation for fecal incontinence and constipation in adult patients with anorectal malformation--a feasibility study in patients with or without sacral dysgenesis. Int J Colorectal Dis (2014) 0.97
Prospective, observational validation of a multivariate small-bowel obstruction model to predict the need for operative intervention. J Am Coll Surg (2011) 0.95
Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion. Dis Colon Rectum (2007) 0.95
Self-efficacy after bariatric surgery for obesity. A population-based cohort study. Appetite (2009) 0.95
Primary pancreatic cystic neoplasms of the pancreas revisited. Part IV: rare cystic neoplasms. Surg Oncol (2011) 0.95
Metabolic and target organ outcomes after total pancreatectomy: Mayo Clinic experience and meta-analysis of the literature. Clin Endocrinol (Oxf) (2010) 0.94
Hydrogen sulfide is a partially redox-independent activator of the human jejunum Na+ channel, Nav1.5. Am J Physiol Gastrointest Liver Physiol (2011) 0.94
Pancreatoduodenectomy for ductal adenocarcinoma in the very elderly; is it safe and justified? J Gastrointest Surg (2010) 0.94
Carbon monoxide activates human intestinal smooth muscle L-type Ca2+ channels through a nitric oxide-dependent mechanism. Am J Physiol Gastrointest Liver Physiol (2004) 0.94
Total knee arthroplasty in morbidly obese patients treated with bariatric surgery: a comparative study. J Arthroplasty (2012) 0.94
Role of VIP and substance P in NANC innervation in the longitudinal smooth muscle of the rat jejunum - influence of extrinsic denervation. J Surg Res (2007) 0.93
The now and future world of restricted work hours for surgeons. Surgery (2003) 0.93
Outcomes of intra-abdominal fungal vs. bacterial infections in severe acute pancreatitis. Am J Gastroenterol (2009) 0.93
Colonoscopic splenic injuries: incidence and management. J Gastrointest Surg (2009) 0.92
Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy. HPB (Oxford) (2010) 0.92
Effect of Roux-en-Y gastric bypass in obese patients with Barrett's esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis (2007) 0.92
Mechanisms of action of the gasotransmitter hydrogen sulfide in modulating contractile activity of longitudinal muscle of rat ileum. J Gastrointest Surg (2010) 0.91
Primary pancreatic cystic neoplasms revisited: part II. Mucinous cystic neoplasms. Surg Oncol (2011) 0.91
Loss of Kitlow progenitors, reduced stem cell factor and high oxidative stress underlie gastric dysfunction in progeric mice. J Physiol (2010) 0.91
Role of the vagus nerve on the development of postoperative ileus. Langenbecks Arch Surg (2010) 0.91
Acute enterocyte adaptation to luminal glucose: a posttranslational mechanism for rapid apical recruitment of the transporter GLUT2. J Gastrointest Surg (2011) 0.90